HucMSC‐exosomes carrying miR‐326 inhibit neddylation to relieve inflammatory bowel disease in mice
Abstract Background Inflammatory bowel disease (IBD) is a group of chronic intestinal inflammation that is a risk factor for many gastrointestinal cancers. Exosomes are gradually gaining attention as an emerging treatment method for IBD due to their important biological characteristics. NF‐κB is an...
Main Authors: | Gaoying Wang, Jintao Yuan, Xiu Cai, Zhiwei Xu, Jingyan Wang, Dickson K.W. Ocansey, Yongmin Yan, Hui Qian, Xu Zhang, Wenrong Xu, Fei Mao |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-06-01
|
Series: | Clinical and Translational Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/ctm2.113 |
Similar Items
-
hucMSC-derived exosomes attenuate colitis by regulating macrophage pyroptosis via the miR-378a-5p/NLRP3 axis
by: Xiu Cai, et al.
Published: (2021-07-01) -
Neddylation Facilitates the Antiviral Response in Zebrafish
by: Guangqing Yu, et al.
Published: (2019-06-01) -
Targeting NEDDylation as a Novel Approach to Improve the Treatment of Head and Neck Cancer
by: Trace M. Jones, et al.
Published: (2021-06-01) -
Advances in Cancer Treatment by Targeting the Neddylation Pathway
by: Wenbin Gai, et al.
Published: (2021-04-01) -
MLN4924, a Protein Neddylation Inhibitor, Suppresses the Growth of Human Chondrosarcoma through Inhibiting Cell Proliferation and Inducing Endoplasmic Reticulum Stress-Related Apoptosis
by: Meng-Huang Wu, et al.
Published: (2018-12-01)